Human Genome Epidemiology Literature Finder
|
Records 1 - 30 (of 108 Records) |
| Query Trace: Disease and ROS1[original query] |
|---|
African ancestry GWAS of dementia in a large military cohort identifies significant risk loci.
Molecular psychiatry 2022 12 28 (3): 1293-1302. Sherva Richard, Zhang Rui, Sahelijo Nathan, Jun Gyungah, Anglin Tori, Chanfreau Catherine, Cho Kelly, Fonda Jennifer R, Gaziano J Michael, Harrington Kelly M, Ho Yuk-Lam, Kremen William S, Litkowski Elizabeth, Lynch Julie, Neale Zoe, Roussos Panos, Marra David, Mez Jesse, Miller Mark W, Salat David H, Tsuang Debby, Wolf Erika, Zeng Qing, Panizzon Matthew S, Merritt Victoria C, Farrer Lindsay A, Hauger Richard L, Logue Mark |
| MET gene amplification is a mechanism of resistance to entrectinib in ROS1+ NSCLC. Thoracic cancer 2022 9 13 (21): 3032-3041. Tyler Logan C, Le Anh T, Chen Nan, Nijmeh Hala, Bao Liming, Wilson Timothy R, Chen David, Simmons Brian, Turner Kristen M, Perusse Dean, Kasibhatla Shailaja, Christiansen Jason, Dudek Arkadiusz Z, Doebele Robert |
| Liquid biopsy for the detection of resistance mutations to ROS1 and RET inhibitors in non-small lung cancers: A case series study. Respiratory investigation 2022 9 60 (6): 852-856. Seki Yoshitaka, Yoshida Tatsuya, Kohno Takashi, Masuda Ken, Okuma Yusuke, Goto Yasushi, Horinouchi Hidehito, Yamamoto Noboru, Kuwano Kazuyoshi, Ohe Yuichi |
| Risk of thromboembolism in non-small-cell lung cancers patients with different oncogenic drivers, including ROS1, ALK, and EGFR mutations. ESMO open 2022 Dec 7 (6): 100742. Wang H-Y, Wu S-G, Lin Y-T, Chen C-Y, Shih J |
| Genetic insights into thymic carcinomas and thymic neuroendocrine neoplasms denote prognosis signatures and pathways. Chinese medical journal 2023 9 . Shuyuan Wang, Zhitao Gu, Lei Zhu, Yuchen Han, Hong Yu, Wentao Fang, Baohui H |
| Utility of multigene panel next-generation sequencing in routine clinical practice for identifying genomic alterations in newly diagnosed metastatic nonsmall cell lung cancer. Internal medicine journal 2023 9 . Udit Nindra, Abhijit Pal, Victoria Bray, Po Y Yip, Annette Tognela, Tara L Roberts, Therese M Becker, Jonathon Williamson, Mahtab Farzin, Jing J Li, Vivienne Lea, Abeer Hagelamin, Weng Ng, Bin Wang, C Soon Lee, Wei Ch |
| Genome-wide Detection of Chimeric Transcripts in Early-stage Non-small Cell Lung Cancer. Cancer genomics & proteomics 2023 8 20 (5): 417-432. Yaroslav Ilnytskyy, Lars Petersen, John B McIntyre, Mie Konno, Adrijana D'Silva, Michelle Dean, Anifat Elegbede, Andrey Golubov, Olga Kovalchuk, Igor Kovalchuk, Gwyn Be |
| TP53 or CDKN2A/B covariation in ALK/RET/ROS1-rearranged NSCLC is associated with a high TMB, tumor immunosuppressive microenvironment and poor prognosis. Journal of cancer research and clinical oncology 2023 6 . Bin Jiang, Liwen Hu, Daling Dong, Zixin Guo, Wei Wei, Chao Wang, Weikang Shao, Ting Ma, Yanhui Chen, Qingyun Li, Weidong |
| The evolution of lung cancer and impact of subclonal selection in TRACERx. Nature 2023 4 616 (7957): 525-533. Frankell Alexander M, Dietzen Michelle, Al Bakir Maise, Lim Emilia L, Karasaki Takahiro, Ward Sophia, Veeriah Selvaraju, Colliver Emma, Huebner Ariana, Bunkum Abigail, Hill Mark S, Grigoriadis Kristiana, Moore David A, Black James R M, Liu Wing Kin, Thol Kerstin, Pich Oriol, Watkins Thomas B K, Naceur-Lombardelli Cristina, Cook Daniel E, Salgado Roberto, Wilson Gareth A, Bailey Chris, Angelova Mihaela, Bentham Robert, Martínez-Ruiz Carlos, Abbosh Christopher, Nicholson Andrew G, Le Quesne John, Biswas Dhruva, Rosenthal Rachel, Puttick Clare, Hessey Sonya, Lee Claudia, Prymas Paulina, Toncheva Antonia, Smith Jon, Xing Wei, Nicod Jerome, Price Gillian, Kerr Keith M, Naidu Babu, Middleton Gary, Blyth Kevin G, Fennell Dean A, Forster Martin D, Lee Siow Ming, Falzon Mary, Hewish Madeleine, Shackcloth Michael J, Lim Eric, Benafif Sarah, Russell Peter, Boleti Ekaterini, Krebs Matthew G, Lester Jason F, Papadatos-Pastos Dionysis, Ahmad Tanya, Thakrar Ricky M, Lawrence David, Navani Neal, Janes Sam M, Dive Caroline, Blackhall Fiona H, Summers Yvonne, Cave Judith, Marafioti Teresa, Herrero Javier, Quezada Sergio A, Peggs Karl S, Schwarz Roland F, Van Loo Peter, Miedema Daniël M, Birkbak Nicolai J, Hiley Crispin T, Hackshaw Allan, Zaccaria Simone, , Jamal-Hanjani Mariam, McGranahan Nicholas, Swanton Charl |
| Efficacy of Immune Checkpoint Inhibitor Plus Chemotherapy in Patients With ROS1-Rearranged Advanced Lung Adenocarcinoma: A Multicenter, Retrospective Cohort Study. JCO precision oncology 2023 3 7 e2200614. Huang Zhe, Yan Huan, Zeng Liang, Xu Qinqin, Guo Wenhuan, Lin Shaoding, Jiang Wenjuan, Wang Zhan, Deng Li, Qin Haoyue, Zhang Xing, Tong Fan, Zhang Ruiguang, Liu Zhaoyi, Zhang Lin, Dong Xiaorong, Yang Nong, Zhang Yongcha |
| Circulating Tumor DNA Dynamics and Treatment Outcome of Regorafenib in Metastatic Colorectal Cancer. Cancer research and treatment 2023 3 . Lee Dae-Won, Lim Yoojoo, Kim Hwang-Phill, Kim Su Yeon, Roh Hanseong, Kang Jun-Kyu, Lee Kyung-Hun, Kim Min Jung, Ryoo Seung-Bum, Park Ji Won, Jeong Seung-Yong, Park Kyu Joo, Kang Gyeong Hoon, Han Sae-Won, Kim Tae-Y |
| Atezolizumab with or without bevacizumab and platinum-pemetrexed in patients with stage IIIB/IV non-squamous non-small cell lung cancer with EGFR mutation, ALK rearrangement or ROS1 fusion progressing after targeted therapies: A multicentre phase II open-label non-randomised study GFPC 06-2018. European journal of cancer (Oxford, England : 1990) 2023 2 183 38-48. Bylicki Olivier, Tomasini Pascale, Radj Gervais, Guisier Florian, Monnet Isabelle, Ricordel Charles, Bigay-Game Laurence, Geier Margaux, Chouaid Christos, Daniel Catherine, Swalduz Aurelie, Toffart Anne-Claire, Doubre Helene, Peloni Jean-Michel, Moreau Diane, Subtil Fabien, Grellard Jean-Michel, Castera Marie, Clarisse Benedicte, Martins-Lavinas Pedro-Henrique, Decroisette Chantal, Greillier Laurent, |
| Genetic Alterations and Risk Factors for Recurrence in Patients with Non-Small Cell Lung Cancer Who Underwent Complete Surgical Resection. Cancers 2023 12 15 (23): . Hwa Kyung Park, Yoo Duk Choi, Ju-Sik Yun, Sang-Yun Song, Kook-Joo Na, Joon Young Yoon, Chang-Seok Yoon, Hyung-Joo Oh, Young-Chul Kim, In-Jae |
| PDL1 and molecular biomarkers expression in non-small cell lung cancer in Tunisian patients. Monaldi archives for chest disease = Archivio Monaldi per le malattie del torace 2023 11 . Yoldez Houcine, Chirine Moussa, Ahmed Ben Abdelaziz, Aida Aya |
| Molecular characteristics and prognostic factors of leptomeningeal metastasis in non-small cell lung cancer. Clinical neurology and neurosurgery 2023 1 225 107572. Liu Xiaocui, Li Guangrui, Zhang Hongmei, Chang Qing, Fang Mei, Lu Chufan, Tian Panpan, Mei Fengj |
| Comparative study of the genomic landscape and tumor microenvironment among large cell carcinoma of the lung, large cell neuroendocrine of the lung, and small cell lung cancer. Medicine 2023 1 102 (4): e32781. Li Fanghua, Yang Yue, Xu Ying, Li Ke, Song Linhong, Xue Yang, Dong Dand |
| Beyond tobacco: genomic disparities in lung cancer between smokers and never-smokers. BMC cancer 2024 8 24 (1): 951. Javiera Garrido, Yanara Bernal, Evelin González, Alejandro Blanco, Gonzalo Sepúlveda-Hermosilla, Matías Freire, Karen Oróstica, Solange Rivas, Katherine Marcelain, Gareth Owen, Carolina Ibañez, Alejandro Corvalan, Marcelo Garrido, Rodrigo Assar, Rodrigo Lizana, Javier Cáceres-Molina, Diego Ampuero, Liliana Ramos, Paola Pérez, Osvaldo Aren, Sara Chernilo, Cristina Fernández, María Loreto Spencer, Jacqueline Flores Aguila, Giuliano Bernal Dossetto, Mónica Ahumada Olea, Germán Rasse, Carolina Sánchez, Maria Galli de Amorim, Thais F Bartelli, Diana Noronha Nunes, Emmanuel Dias-Neto, Helano C Freitas, Ricardo Armis |
| Co-Occurring Driver Genomic Alterations in Advanced Non-Small-Cell Lung Cancer (NSCLC): A Retrospective Analysis. Journal of clinical medicine 2024 8 13 (15): . Ilaria Attili, Riccardo Asnaghi, Davide Vacirca, Riccardo Adorisio, Alessandra Rappa, Alberto Ranghiero, Mariano Lombardi, Carla Corvaja, Valeria Fuorivia, Ambra Carnevale Schianca, Pamela Trillo Aliaga, Gianluca Spitaleri, Ester Del Signore, Juliana Guarize, Lorenzo Spaggiari, Elena Guerini-Rocco, Nicola Fusco, Filippo de Marinis, Antonio Passa |
| The influence of nutritional status, lipid profile, leptin concentration and polymorphism of genes encoding leptin and neuropeptide Y on the effectiveness of immunotherapy in advanced NSCLC patients. BMC cancer 2024 8 24 (1): 937. Ma?gorzata Fr?k, Anna Grenda, Pawe? Krawczyk, Barbara Ku?nar-Kami?ska, Pawe? Pazdrowski, Karolina K?dra, Izabela Chmielewska, Janusz Milanows |
| Correlation analysis between driver gene mutation and clinicopathological features in lung adenocarcinoma based on real-world cumulative clinical data. Translational lung cancer research 2024 7 13 (6): 1296-1306. Sheng Lu, Aotian Guo, Haichuan Hu, Xinxin Ying, Yao Li, Zhengwei Huang, Wangjue Xu, Shen Tao, Xiaotong Hu, Na Yan, Xuan Zhang, Dan Shen, Takaaki Sasaki, Surein Arulananda, Ken Onodera, Zhengfu |
| Serial Cell-Free DNA Sequencing in ROS1 Fusion-Positive Lung Cancers During Treatment With Entrectinib. JCO precision oncology 2024 6 8 e2300721. Noura J Choudhury, Hyung Jun Woo, Monica Chen, Ronak Shah, Mark Donoghue, Michael Berger, Alexander Dril |
| Association of PD-L1 expression and clinical outcomes in ROS1 - rearranged advanced non-small cell lung cancer treated with crizotinib. Frontiers in oncology 2024 6 14 1405683. Huixian Zhang, Ziheng Zhang, Ningning Yan, Xingya |
| Associations between Radiomics and Genomics in Non-Small Cell Lung Cancer Utilizing Computed Tomography and Next-Generation Sequencing: An Exploratory Study. Genes 2024 6 15 (6): . Alessandro Ottaiano, Francesca Grassi, Roberto Sirica, Emanuela Genito, Giovanni Ciani, Vittorio Patanè, Riccardo Monti, Maria Paola Belfiore, Fabrizio Urraro, Mariachiara Santorsola, Alfonso Maria Ponsiglione, Marco Montella, Salvatore Cappabianca, Alfonso Reginelli, Mario Sansone, Giovanni Savarese, Roberta Gras |
| Completion of Pembrolizumab in Advanced Non-Small Cell Lung Cancer-Real World Outcomes After Two Years of Therapy (COPILOT). Clinical lung cancer 2024 5 . Andrew Fantoni, Lydia Warburton, Benjamin Solomon, Marliese Alexander, Meghana Maddula, Lauren Julia Brown, Ines Pires da Silva, Adnan Nagrial, Farah Abu Al-Hial, Malinda Itchins, Nick Pavlakis, Samantha Bowy |
| Evaluation of molecular residual disease in operable non-small cell lung cancer with gene fusions, MET exon skipping or de novo MET amplification. Frontiers of medicine 2024 5 . Rui Fu, Yuanyuan Xiong, Miao Cai, Fang Li, Rongrong Chen, Yilong Wu, Wenzhao Zho |
| Prognostic Value of KRAS/TP53 Status for Overall Survival in First-Line Monoimmunotherapy and Chemoimmunotherapy Treated Patients With Nonsquamous NSCLC in the Netherlands: A Brief Report. JTO clinical and research reports 2024 12 5 (12): 100745. Vincent D de Jager, Léon C van Kempen, Betzabel N Cajiao Garcia, T Jeroen N Hiltermann, Anthonie J van der Wekken, Ed Schuuring, Stefan M Wille |
| Brief Report: Final overall survival and long-term safety of lorlatinib in patients with ALK-positive non-small cell lung cancer from the pivotal phase 2 study. Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2024 11 . Sai-Hong Ignatius Ou, Benjamin J Solomon, Benjamin Besse, Alessandra Bearz, Chia-Chi Lin, Rita Chiari, D Ross Camidge, Jessica J Lin, Antonello Abbattista, Francesca Toffalorio, Ross A S |
| Prospective study of the real impact of fusion centered genomic assays in patient management in a national collaborative group: the GETHI-XX-16 study. Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico 2024 11 . Paloma Navarro, Carmen Beato, Juan Francisco Rodriguez-Moreno, Sergio Ruiz-Llorente, Xabier Mielgo, Estela Pineda, Miguel Navarro, Gema Bruixola, Tatiana P Grazioso, Antonio Viudez, Jose Fuster, Esther Nogueron, Maria Dolores Mediano, Carmen Balaña, Carlos Mendez, Rosa María Rodriguez, Sonia Del Barco Berron, Beatriz Gongora, Alberto Carmona-Bayonas, Jesus Garcia-Don |
| CDX2-Suppressed Colorectal Cancers Possess Potentially Targetable Alterations in Receptor Tyrosine Kinases and Other Colorectal-Cancer-Associated Pathways. Diseases (Basel, Switzerland) 2024 10 12 (10): . Ioannis A Voutsadak |
| Brain radiotherapy combined with camrelizumab and platinum-doublet chemotherapy for previously untreated advanced non-small-cell lung cancer with brain metastases (C-Brain): a multicentre, single-arm, phase 2 trial. The Lancet. Oncology 2025 1 26 (1): 74-84. Yanjun Xu, Kaiyan Chen, Yujin Xu, Hui Li, Zhiyu Huang, Hongyang Lu, Dingzhi Huang, Sizhe Yu, Na Han, Lei Gong, Jing Qin, Jun Chen, Fajun Xie, Wei Hong, Xiao Lin, Fengzhuo Cheng, Xiaojie Luo, Yun F |
- Page last reviewed:Feb 1, 2024
- Content source: